Christine Mossa

Senior Director of Regulatory Affairs, Public Affairs, Value & Access

Christine Mossa joined Ipsen Canada in 2018 and quickly advanced to her current role overseeing the development and implementation of regulatory and market access strategies for all marketed and developmental products. Christine also plays a key role in representing Ipsen externally with government and industry associations to influence the pharmaceutical operating environment in Canada. In addition to ensuring business goals are met while aligning Regulatory Affairs services and Market Access needs, Christine is also responsible for Ipsen Canada’s Patient Support Programs and Canadian Quality Operations.

Before joining Ipsen Canada, Christine held positions including Director of Regulatory Affairs at Purdue Pharma and Team Lead, Reimbursement Strategy at GlaxoSmithKline.

Christine is a certified Project Management Professional and holds post-graduate certificates from Humber College in Project Management and Regulatory Affairs and an Executive Certificate in Management and Leadership from the MIT Sloan School of Management. She studied Pharmacology/Toxicology at the University of Toronto and has an Honours Bachelor of Science degree in Biology and Psychology from McMaster University.

Our mission

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare disease.

Find out more about us or see other members of our leadership team.


Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products


Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

What’s happening now?

See the latest
©2020 Ipsen Biopharmaceuticals, Inc. All rights reserved. June 2020 CR-CA-000013